We track the compounds moving through translational research, profile the molecules biohackers and longevity researchers care about, and publish dosing, safety, and protocol analysis with the citations to back it up.
Body Protection Compound-157 — three decades of pre-clinical data on tissue repair, angiogenesis, and the gut-brain axis.
Pre-clinical · Phase IIThe active fragment of Thymosin Beta-4 driving actin remodeling, cell migration, and the modern recovery-protocol category.
Pre-clinical · Phase IICopper tripeptide that resets ~4,000 genes toward youthful expression patterns — the most-cited peptide in cosmeceutical science.
Cosmeceutical · ApprovedKhavinson's tetrapeptide — telomerase activator with the largest human longevity dataset of any peptide on this site.
Clinical · Phase IIIThe cleanest of the GHS class — minimal cortisol/prolactin spillover, workhorse of modern GH-axis protocols.
Pre-clinical · Phase IIThe albumin-binding GHRH analog (DAC) that made sustained GH-axis stimulation a once-weekly protocol.
Clinical · Phase IIMost peptide coverage online is one of two things: cosmetic-grade marketing copy from compounding pharmacies, or thread-based folklore from forum culture. Neither is wrong on every point and neither is right on most.
Revolutionary Peptides reads the actual translational pipeline — the IND filings, the conference abstracts, the pre-clinical animal data, the Phase I tolerability work — and translates it into compound coverage that biohackers, longevity researchers, and early-stage adopters can actually use to make decisions.
We name our author. We cite our work. We hedge where the data hedges. And we maintain zero vendor relationships — no affiliate deals, no compounding-pharmacy sponsorships, no "preferred supplier" lists.
Including Selank, Semax, Pinealon, Cerebrolysin fractions, PT-141, melanotan derivatives, and four undisclosed cyclic peptides in Phase I tolerability.
Every protocol on this site starts at the lowest tolerated published dose. Read our screening framework before you read anything else.
If you've never worked with research peptides, these four pages cover the entire conceptual foundation — biochemistry, dosing, handling, and safety.
Biochemistry primer. What separates a peptide from a small molecule and why that pharmacology matters.
Published ranges, frequency logic, titration patterns, and where the data ends.
Lyophilization, BAC water, dilution math, and the chain-of-custody habits that preserve potency.
Screening, contraindications, monitoring, and the AE patterns documented in case literature.